Drug Approval
BioMarin Going for 2020 Approval of its Hemophilia A Gene Therapy
Pharma's Almanac
PAO-M08-19-NI-026Aug 22, 2019
Recall
Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States
Nice Insight
PR-M07-19-NI-062Jul 24, 2019
Drug Development
Bayer Gets FDA Approval for Hemophilia A Drug
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-006Sep 06, 2018
Clinical Trial
Sangamo Announces Positive Preliminary Data from the Phase 1/2 Alta Study Evaluating SB-525 Gene Therapy for Hemophilia A
Sangamo Therapeutics
PR-M08-18-NI-113Aug 29, 2018
Cell and Gene Therapy
Shire Submits IND for Hemophilia A Gene Therapy
Nigel Walker
Nice Insight
PAO-M07-17-NI-016Jul 13, 2017